Apalutamide (APA) for metastatic castration-sensitive prostate cancer (mCSPC) in TITAN: Outcomes in patients (pts) with de novo (D1) mCSPC vs. progression to mCSPC after localized disease (D0) at diagnosis

• A.S. Bjartell,
• D. Ye,
• N. Agarwal,
• B.H. Chung,
• R. Given,
• A. Merseburger,
• M. Özgüroğlu,
• A. Juárez Soto,
• H. Uemura,
• A. Lopez-Gitlitz,
• G. Li,
• S. Mc Carthy,
• K.N. Chi,
• S. Chowdhury

Affiliations

A.S. Bjartell

D. Ye

N. Agarwal

B.H. Chung

R. Given

A. Merseburger

M. Özgüroğlu

A. Juárez Soto

H. Uemura

A. Lopez-Gitlitz

G. Li

S. Mc Carthy

K.N. Chi

S. Chowdhury